Cargando…
Parenteral Nutrition Process Management for Newborn and Preterm Infants – A Preliminary Risk Analysis
BACKGROUND: There are variable practices in the management of the parenteral nutrition (PN) process in hospitals having a neonatal intensive care unit (NICU). In our hospital, PN is prepared partially on the neonatal ward by nurses but also at the central pharmacy by trained pharmacy technicians. A...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169048/ https://www.ncbi.nlm.nih.gov/pubmed/34093016 http://dx.doi.org/10.2147/TCRM.S280938 |
_version_ | 1783701980058746880 |
---|---|
author | Sommer, Isabelle Palmero, David Fischer Fumeaux, Céline Julie Bonnabry, Pascal Bouchoud, Lucie Sadeghipour, Farshid |
author_facet | Sommer, Isabelle Palmero, David Fischer Fumeaux, Céline Julie Bonnabry, Pascal Bouchoud, Lucie Sadeghipour, Farshid |
author_sort | Sommer, Isabelle |
collection | PubMed |
description | BACKGROUND: There are variable practices in the management of the parenteral nutrition (PN) process in hospitals having a neonatal intensive care unit (NICU). In our hospital, PN is prepared partially on the neonatal ward by nurses but also at the central pharmacy by trained pharmacy technicians. A previous study showed a concentration non-conformity of 34% of on-ward PN preparations potentially resulting in under- or overfeeding of the patients. OBJECTIVE: The objectives were to perform preliminary risk analyses (PRA) in preparation for our hospital’s transition to universal central pharmacy PN compounding. METHODS: A working group including pharmacists, neonatologists, nurses, and pharmacy technicians performed two PRA. The risks of 9 management steps of the PN process were identified, evaluated, and quoted. A comparison of the number of risks and their criticality index (CI) was conducted. RESULTS: A total of 36 and 39 risks were identified for PN preparation in the NICU and the pharmacy, respectively. For the NICU, ten risks (28%) had an “acceptable” CI, 15 risks (42%) were “under control” and eleven (31%) were defined as “non-acceptable”. For the pharmacy, 14 risks (36%) had an “acceptable” CI, 19 risks (49%) were “under control” and six (15%) were defined as “non-acceptable”. Risks directly related to the preparation process, including the steps preparation hood, PN preparation and analytical quality control, represented a cumulated CI of 145 for eleven NICU-risks vs 108 for twelve pharmacy risks (−26%). The implementation of immediate improvement measures, eg, an electronic prescription form, reduces the total CI by 5.7% and 2.2% for the NICU and the pharmacy, respectively. CONCLUSION: This PRA highlighted the safety differences between PN preparation in the NICU vs the pharmacy at our institution, and facilitated our moving forward with a process change that should improve the care of our neonatal patients. Nevertheless, long-term improvement measures have to be implemented to further reduce risks related to the PN management process. |
format | Online Article Text |
id | pubmed-8169048 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-81690482021-06-03 Parenteral Nutrition Process Management for Newborn and Preterm Infants – A Preliminary Risk Analysis Sommer, Isabelle Palmero, David Fischer Fumeaux, Céline Julie Bonnabry, Pascal Bouchoud, Lucie Sadeghipour, Farshid Ther Clin Risk Manag Original Research BACKGROUND: There are variable practices in the management of the parenteral nutrition (PN) process in hospitals having a neonatal intensive care unit (NICU). In our hospital, PN is prepared partially on the neonatal ward by nurses but also at the central pharmacy by trained pharmacy technicians. A previous study showed a concentration non-conformity of 34% of on-ward PN preparations potentially resulting in under- or overfeeding of the patients. OBJECTIVE: The objectives were to perform preliminary risk analyses (PRA) in preparation for our hospital’s transition to universal central pharmacy PN compounding. METHODS: A working group including pharmacists, neonatologists, nurses, and pharmacy technicians performed two PRA. The risks of 9 management steps of the PN process were identified, evaluated, and quoted. A comparison of the number of risks and their criticality index (CI) was conducted. RESULTS: A total of 36 and 39 risks were identified for PN preparation in the NICU and the pharmacy, respectively. For the NICU, ten risks (28%) had an “acceptable” CI, 15 risks (42%) were “under control” and eleven (31%) were defined as “non-acceptable”. For the pharmacy, 14 risks (36%) had an “acceptable” CI, 19 risks (49%) were “under control” and six (15%) were defined as “non-acceptable”. Risks directly related to the preparation process, including the steps preparation hood, PN preparation and analytical quality control, represented a cumulated CI of 145 for eleven NICU-risks vs 108 for twelve pharmacy risks (−26%). The implementation of immediate improvement measures, eg, an electronic prescription form, reduces the total CI by 5.7% and 2.2% for the NICU and the pharmacy, respectively. CONCLUSION: This PRA highlighted the safety differences between PN preparation in the NICU vs the pharmacy at our institution, and facilitated our moving forward with a process change that should improve the care of our neonatal patients. Nevertheless, long-term improvement measures have to be implemented to further reduce risks related to the PN management process. Dove 2021-05-28 /pmc/articles/PMC8169048/ /pubmed/34093016 http://dx.doi.org/10.2147/TCRM.S280938 Text en © 2021 Sommer et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Sommer, Isabelle Palmero, David Fischer Fumeaux, Céline Julie Bonnabry, Pascal Bouchoud, Lucie Sadeghipour, Farshid Parenteral Nutrition Process Management for Newborn and Preterm Infants – A Preliminary Risk Analysis |
title | Parenteral Nutrition Process Management for Newborn and Preterm Infants – A Preliminary Risk Analysis |
title_full | Parenteral Nutrition Process Management for Newborn and Preterm Infants – A Preliminary Risk Analysis |
title_fullStr | Parenteral Nutrition Process Management for Newborn and Preterm Infants – A Preliminary Risk Analysis |
title_full_unstemmed | Parenteral Nutrition Process Management for Newborn and Preterm Infants – A Preliminary Risk Analysis |
title_short | Parenteral Nutrition Process Management for Newborn and Preterm Infants – A Preliminary Risk Analysis |
title_sort | parenteral nutrition process management for newborn and preterm infants – a preliminary risk analysis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169048/ https://www.ncbi.nlm.nih.gov/pubmed/34093016 http://dx.doi.org/10.2147/TCRM.S280938 |
work_keys_str_mv | AT sommerisabelle parenteralnutritionprocessmanagementfornewbornandpreterminfantsapreliminaryriskanalysis AT palmerodavid parenteralnutritionprocessmanagementfornewbornandpreterminfantsapreliminaryriskanalysis AT fischerfumeauxcelinejulie parenteralnutritionprocessmanagementfornewbornandpreterminfantsapreliminaryriskanalysis AT bonnabrypascal parenteralnutritionprocessmanagementfornewbornandpreterminfantsapreliminaryriskanalysis AT bouchoudlucie parenteralnutritionprocessmanagementfornewbornandpreterminfantsapreliminaryriskanalysis AT sadeghipourfarshid parenteralnutritionprocessmanagementfornewbornandpreterminfantsapreliminaryriskanalysis |